Cargando…
Acute myocardial infarction after laboratory confirmed SARS-CoV-2 infection
Autores principales: | Ena, J., Bou-Collado, M., Reyes-Jara, M.D., Afonso-Carrillo, R., Mulet, R., Valls, V. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier B.V.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8415844/ http://dx.doi.org/10.1016/j.atherosclerosis.2021.06.873 |
Ejemplares similares
-
The first laboratory-confirmed imported infections of SARS-CoV-2 in Sudan
por: Aljak, Elham R, et al.
Publicado: (2020) -
Predictors of severe symptomatic laboratory-confirmed SARS-CoV-2 reinfection
por: Murillo-Zamora, E., et al.
Publicado: (2021) -
Laboratory-confirmed influenza infection and acute myocardial infarction among United States senior Veterans
por: Young-Xu, Yinong, et al.
Publicado: (2020) -
Acute myocardial infarctions and stroke triggered by laboratory-confirmed respiratory infections in Denmark, 2010 to 2016
por: Ohland, Jessica, et al.
Publicado: (2020) -
Laboratory-confirmed SARS-CoV-2 reinfection in the population treated at social security
por: Santiago-Espinosa, Oscar, et al.
Publicado: (2021)